You may be entitled to compensation if your child was diagnosed with hypophosphatemia – low levels of phosphate in the blood – while being fed a Neocate Formula product.
Your family may be eligible to take legal action if your infant or child was diagnosed with low phosphate levels while being fed a Neocate amino acid formula product, including:
The nationwide law firm of Bernstein Liebhard LLP is offering free legal reviews to families interested in filing a Neocate Formula hypophosphatemia lawsuit on behalf of their child. To learn more, please call (888) 994-5118 or fill out the form on this page.
Amino acid or elemental formulas like Neocate are designed to be hypoallergenic and easy to digest for infants and children who suffer from:
However, a study published in the medical journal Bone in April 2017 linked Neocate Formula to hypophosphatemia. The study involved 51 children who were diagnosed with the condition, many of whom had only been fed Neocate for variable periods of time prior to their diagnosis. Skeletal radiographs demonstrated fractures, undermineralization, or rickets in 94% of the cases.
Most tellingly, all of the children improved once they were given supplement phosphate or switched to a new formula.
Phosphate contains the mineral phosphorus, which the body needs to repair bones and teeth. Phosphorus also aids in nerve function and helps the muscles contract.
While some phosphorus is stored in tissues throughout the body, about 85% is stored in the bones.
Phosphorus can be found naturally in food. Good sources include:
Hypophosphatemia is an electrolyte disturbance in which there is an abnormally low level of phosphate in the blood.
Signs of this condition include:
Chronic hypophosphatemia that accompanies chronic phosphate deficiency can result in significant bone disease.
You may be eligible for compensation if your infant or child was fed Neocate Formula and developed hypophosphatemia.
To learn more about filing a Neocate Formula hypophosphatemia lawsuit, please call (888) 994-5118 or fill out the form on this page.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.